• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与衰变加速因子(CD55)结合的艾柯病毒的特性:一些血凝性毒株使用不止一种细胞受体的证据。

Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.

作者信息

Powell R M, Schmitt V, Ward T, Goodfellow I, Evans D J, Almond J W

机构信息

School of Animal and Microbial Sciences, University of Reading, Whiteknights, UK.

出版信息

J Gen Virol. 1998 Jul;79 ( Pt 7):1707-13. doi: 10.1099/0022-1317-79-7-1707.

DOI:10.1099/0022-1317-79-7-1707
PMID:9680134
Abstract

Several echoviruses (EVs) have previously been shown to use decay accelerating factor (DAF) as a cellular receptor. Since DAF is expressed on erythrocytes, EVs that use this receptor cause haemagglutination. Here we show that all EVs that haemagglutinate do so via attachment to DAF and that this interaction can be inhibited by a monoclonal antibody (MAb) specific for DAF domain SCR3. Although the viruses haemagglutinate via DAF some can bind to rhabdomyosarcoma cells from which DAF has been removed and infect in the presence of a MAb against DAF. This suggests that some EVs have the capacity to interact with more than one cellular receptor.

摘要

先前已证明几种肠道病毒(EVs)利用衰变加速因子(DAF)作为细胞受体。由于DAF在红细胞上表达,利用该受体的EVs会引起血细胞凝集。在此我们表明,所有具有血细胞凝集作用的EVs都是通过与DAF结合来实现的,并且这种相互作用可被针对DAF结构域SCR3的单克隆抗体(MAb)抑制。尽管这些病毒通过DAF引起血细胞凝集,但有些病毒可以与已去除DAF的横纹肌肉瘤细胞结合,并在存在抗DAF单克隆抗体的情况下感染细胞。这表明一些EVs有能力与不止一种细胞受体相互作用。

相似文献

1
Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.与衰变加速因子(CD55)结合的艾柯病毒的特性:一些血凝性毒株使用不止一种细胞受体的证据。
J Gen Virol. 1998 Jul;79 ( Pt 7):1707-13. doi: 10.1099/0022-1317-79-7-1707.
2
Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.将人类衰变加速因子(DAF)用作受体的艾柯病毒和柯萨奇B病毒不会与DAF的啮齿动物类似物结合。
J Infect Dis. 2000 Jan;181(1):340-3. doi: 10.1086/315210.
3
Echoviruses bind heparan sulfate at the cell surface.艾柯病毒在细胞表面与硫酸乙酰肝素结合。
J Virol. 2001 May;75(10):4918-21. doi: 10.1128/JVI.75.10.4918-4921.2001.
4
Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59.
J Gen Virol. 2000 May;81(Pt 5):1393-401. doi: 10.1099/0022-1317-81-5-1393.
5
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.抗体与衰变加速因子的单个短共有重复序列结合可增强肠道病毒的细胞附着和感染性。
J Immunol. 1998 Mar 1;160(5):2318-23.
6
Interaction of decay-accelerating factor with coxsackievirus B3.衰变加速因子与柯萨奇病毒B3的相互作用
J Virol. 2007 Dec;81(23):12927-35. doi: 10.1128/JVI.00931-07. Epub 2007 Sep 5.
7
Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.两簇突变分别定位了埃可病毒11与衰变加速因子(CD55)以及峡谷结合受体结合的不同受体结合位点。
Virus Res. 2009 Oct;145(1):74-9. doi: 10.1016/j.virusres.2009.06.004. Epub 2009 Jun 18.
8
Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.衰变加速因子(CD55)是一种糖基磷脂酰肌醇锚定的补体调节蛋白,是几种艾柯病毒的受体。
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6245-8. doi: 10.1073/pnas.91.13.6245.
9
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.与柯萨奇病毒和腺病毒受体相互作用,而非与衰变加速因子(DAF)相互作用,会在一种结合DAF的柯萨奇病毒B3分离株中诱导A颗粒形成。
J Virol. 2005 Jan;79(1):655-60. doi: 10.1128/JVI.79.1.655-660.2005.
10
Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection.建立一种重组 CHO 细胞模型,用于研究 CAR 和 DAF 在肠道病毒 6 感染早期阶段的作用。
Virus Res. 2011 Jun;158(1-2):46-54. doi: 10.1016/j.virusres.2011.03.009. Epub 2011 Mar 21.

引用本文的文献

1
An Overview of the Characteristics, Pathogenesis, Epidemiology, and Detection of Human Enterovirus in the Arabian Gulf Region.《阿拉伯海湾地区人类肠道病毒的特征、发病机制、流行病学和检测概述》。
Viruses. 2024 Jul 24;16(8):1187. doi: 10.3390/v16081187.
2
Switching of Receptor Binding Poses between Closely Related Enteroviruses.密切相关肠道病毒间受体结合构象的转换。
Viruses. 2022 Nov 24;14(12):2625. doi: 10.3390/v14122625.
3
Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B.
中和抗体识别的血清型特异性表位是肠道病毒 B 免疫原性差异的基础。
Nat Commun. 2020 Sep 4;11(1):4419. doi: 10.1038/s41467-020-18250-w.
4
Early Entry Events in Echovirus 30 Infection.肠道病毒 30 感染的早期进入事件。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00592-20.
5
Recent advances on the role of host factors during non-poliovirus enteroviral infections.宿主因素在非脊髓灰质炎肠道病毒感染中的作用的最新进展。
J Biomed Sci. 2019 Jun 19;26(1):47. doi: 10.1186/s12929-019-0540-y.
6
Enterovirus D68 receptor requirements unveiled by haploid genetics.单倍体遗传学揭示肠道病毒D68的受体需求
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1399-404. doi: 10.1073/pnas.1524498113. Epub 2016 Jan 19.
7
Rhinoviruses and Respiratory Enteroviruses: Not as Simple as ABC.鼻病毒和呼吸道肠道病毒:并非像ABC那么简单。
Viruses. 2016 Jan 11;8(1):16. doi: 10.3390/v8010016.
8
Cytolytic replication of echoviruses in colon cancer cell lines.肠病毒在结肠癌细胞系中的细胞溶解性复制。
Virol J. 2011 Oct 14;8:473. doi: 10.1186/1743-422X-8-473.
9
Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells.柯萨奇病毒 A24 变体利用人眼细胞表面含唾液酸的 O-连接糖缀合物作为细胞受体。
J Virol. 2011 Nov;85(21):11283-90. doi: 10.1128/JVI.05597-11. Epub 2011 Aug 31.
10
Molecular determinants of disease in coxsackievirus B1 murine infection.柯萨奇病毒 B1 感染小鼠疾病的分子决定因素。
J Med Virol. 2011 Sep;83(9):1571-81. doi: 10.1002/jmv.22133.